117 related articles for article (PubMed ID: 37349199)
1. Association of Computed Tomography Radiomics Signature with Progression-free Survival in Neuroblastoma Patients.
Wang H; Li T; Xie M; Si J; Qin J; Yang Y; Zhang L; Ding H; Chen X; He L
Clin Oncol (R Coll Radiol); 2023 Nov; 35(11):e639-e647. PubMed ID: 37349199
[TBL] [Abstract][Full Text] [Related]
2. Identification of an Ultra-High-Risk Subgroup of Neuroblastoma Patients within the High-Risk Cohort Using a Computed Tomography-Based Radiomics Approach.
Wang H; Chen X; Li T; Xie M; Qin J; Zhang L; Ding H; He L
Acad Radiol; 2024 Apr; 31(4):1655-1665. PubMed ID: 37714717
[TBL] [Abstract][Full Text] [Related]
3. Computed Tomography-Based Radiomics Signature for Predicting Segmental Chromosomal Aberrations at 1p36 and 11q23 in Pediatric Neuroblastoma.
Wang H; Yu C; Ding H; Zhang L; Chen X; He L
J Comput Assist Tomogr; 2024 May-Jun 01; 48(3):472-479. PubMed ID: 38013242
[TBL] [Abstract][Full Text] [Related]
4. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
5. CT-based radiomics signature analysis for evaluation of response to induction chemotherapy and progression-free survival in locally advanced hypopharyngeal carcinoma.
Liu X; Long M; Sun C; Yang Y; Lin P; Shen Z; Xia S; Shen W
Eur Radiol; 2022 Nov; 32(11):7755-7766. PubMed ID: 35608663
[TBL] [Abstract][Full Text] [Related]
6. A CT-based radiomics nomogram for predicting the progression-free survival in small cell lung cancer: a multicenter cohort study.
Zheng X; Liu K; Li C; Zhu C; Gao Y; Li J; Wu X
Radiol Med; 2023 Nov; 128(11):1386-1397. PubMed ID: 37597124
[TBL] [Abstract][Full Text] [Related]
7.
Xu X; Sun X; Ma L; Zhang H; Ji W; Xia X; Lan X
Front Oncol; 2023; 13():1149791. PubMed ID: 36969043
[TBL] [Abstract][Full Text] [Related]
8. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
[No Abstract] [Full Text] [Related]
9. Computed tomography-based radiomics signature as a pretreatment predictor of progression-free survival in locally advanced hypopharyngeal carcinoma with a different response to induction chemotherapy.
Liu X; Sun C; Long M; Yang Y; Lin P; Xia S; Shen W
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3551-3562. PubMed ID: 35212776
[TBL] [Abstract][Full Text] [Related]
10. Radiogenomics of neuroblastoma in pediatric patients: CT-based radiomics signature in predicting MYCN amplification.
Wu H; Wu C; Zheng H; Wang L; Guan W; Duan S; Wang D
Eur Radiol; 2021 May; 31(5):3080-3089. PubMed ID: 33118047
[TBL] [Abstract][Full Text] [Related]
11. Preoperative prediction for lauren type of gastric cancer: A radiomics nomogram analysis based on CT images and clinical features.
Sun Z; Jin L; Zhang S; Duan S; Xing W; Hu S
J Xray Sci Technol; 2021; 29(4):675-686. PubMed ID: 34024809
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of
Feng L; Yang X; Lu X; Kan Y; Wang C; Zhang H; Wang W; Yang J
Acad Radiol; 2023 May; 30(5):940-951. PubMed ID: 36117128
[TBL] [Abstract][Full Text] [Related]
13. Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy.
Ye S; Han Y; Pan X; Niu K; Liao Y; Meng X
Front Oncol; 2022; 12():843991. PubMed ID: 35692757
[TBL] [Abstract][Full Text] [Related]
14. Clinical parameters combined with radiomics features of PET/CT can predict recurrence in patients with high-risk pediatric neuroblastoma.
Feng L; Qian L; Yang S; Ren Q; Zhang S; Qin H; Wang W; Wang C; Zhang H; Yang J
BMC Med Imaging; 2022 May; 22(1):102. PubMed ID: 35643445
[TBL] [Abstract][Full Text] [Related]
15. Contrast computed tomography-based radiomics is correlation with COG risk stratification of neuroblastoma.
Zhang Y; Yang Y; Ning G; Wu X; Yang G; Li Y
Abdom Radiol (NY); 2023 Jun; 48(6):2111-2121. PubMed ID: 36951989
[TBL] [Abstract][Full Text] [Related]
16. Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.
Nie P; Yang G; Wang N; Yan L; Miao W; Duan Y; Wang Y; Gong A; Zhao Y; Wu J; Zhang C; Wang M; Cui J; Yu M; Li D; Sun Y; Wang Y; Wang Z
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):217-230. PubMed ID: 32451603
[TBL] [Abstract][Full Text] [Related]
17. An Optimal Radiomics Nomogram Based on
Feng L; Zhang S; Lu X; Yang X; Kan Y; Wang C; Zhang H; Wang W; Yang J
Acad Radiol; 2023 Oct; 30(10):2309-2320. PubMed ID: 37393177
[TBL] [Abstract][Full Text] [Related]
18. An
Feng L; Lu X; Yang X; Kan Y; Sun D; Wang W; Yang J
Eur J Radiol; 2022 Sep; 154():110444. PubMed ID: 35917754
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Central Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma by CT Radiomics.
Peng Y; Zhang ZT; Wang TT; Wang Y; Li CH; Zuo MJ; Lin HS; Gong LG
Acad Radiol; 2023 Jul; 30(7):1400-1407. PubMed ID: 36220726
[TBL] [Abstract][Full Text] [Related]
20. A CT-based radiomics signature for prediction of HER2 overexpression and treatment efficacy of trastuzumab in advanced gastric cancer.
Ma T; Cui J; Wang L; Li H; Ye Z; Gao X
Transl Cancer Res; 2022 Dec; 11(12):4326-4337. PubMed ID: 36644192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
